SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
Cellectar Biosciences, Inc.
@CLRB_InsiderForm 4 Filing: CARUSO JAMES V Acquires (Grant) shares of $CLRB
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Cellectar Biosciences, Inc.
Ticker: $CLRB
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-07
Shares: 250,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, CARUSO JAMES V, holds the title of President & CEO at Cellectar Biosciences, Inc..
On 2026-07-07, the insider transacted 250,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
CARUSO JAMES V (President & CEO) was granted $0 of $CLRB
Post-Transaction Position: 250,000 shares
SEC Accession No: 0001104659-26-082014 (CIK: 1202770)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.